 |
| Europe Scar Treatment Market |
The Europe scar treatment market size was valued at
$5.2 billion in 2016, which is expected to reach $9.8 billion by 2023, growing
at a CAGR of 9.6% during the forecast period (2017-2023).
Topical scar treatment is expected to witness highest growth
during the forecast period in the European scar treatment market due to
increasing disposable income, rising prevalence of chronic wounds and
availability of different types of topical scar treatment products. Topical
scar treatment is followed by surface scar treatment, laser scar
treatment, injectable scar treatment, invasive surgical scar treatment.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market/report-sample
The technological advancements and rising awareness about skin
related problems and their available treatments are also key factors leading to
the growth of the European scar treatment market. For instance, in February
2017, Lumenis Ltd. supported International Scar Treatment Conference in Israel,
held in Tel Aviv, focused on spreading awareness about the interdisciplinary
approach for successful management of scars. According to the European Wound
Management Association (EWMA), around 4 million wound cases are reported every
year in the Europe. This in turn, is driving the demand for scar treatment
products in the region. Furthermore, according to the OECD, the German
household disposable income was $34,887.8 in 2014, compared to $34,286.2 in
2013.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=europe-scar-treatment-market
Some of the key players operating in the European scar treatment
market include Merz GmbH & Company KGAA, Mölnlycke Health Care AB, Smith
& Nephew Plc, Syneron Medical Ltd., Lumenis Ltd., L'oreal S.A, H&R
Healthcare Ltd., Avita Medical, Arbonne International, and Laverana GmbH &
Co.KG.
No comments:
Post a Comment